14. SynBio Revolution: Arvind Gupta - Partner @ Mayfield Fund / Founder @ IndieBio

Guest: Arvind Gupta (@ArvndGpta) - Partner @ Mayfield Fund / Founder @ IndieBio

Hosts: Chas Pulido (@AlixVentures) & Amee Kapadia

Arvind Gupta is a Partner @ Mayfield Fund where he co-leads the Engineering Biology practice. He was the first investor in several breakout biology companies including Geltor, Prellis, Synthex, and Memphis Meats. Prior to joining Mayfield, Arvind was a founder of Indie Bio, the world’s leading biotech accelerator. At IndieBio, he was fundamental to the growth of the accelerator, building a $3.2B portfolio and investing in over 136 companies over five years. He is particularly passionate about conscious capitalism and continues to serve as a Venture Advisor at IndieBio. 

Topics:

  • Career journey from design to biotech investing

  • Personal mission statements

  • Synthetic biology guiding the biotech revolution

  • Conscious capital and engineering biology

  • What to expect for the future of “tech bio”

  • How VC will evolve with new capital structures in biotech

  • Advice for life sciences founders

Thank you for listening!

BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.

Music: Danger Storm by Kevin MacLeod (link & license

————————————————————————————————

Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.

Previous
Previous

15. Bio + Tech: Zavain Dar - Partner @ Lux Capital

Next
Next

13. Bio-Industrial Age: Francisco Gimenez & David Moskowitz - 8VC Bio Team